The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes
The NK-PSS-M model improved the risk stratification of non-molecular models and provided a reliable alternative to the IPSS-M. This strategy provides insights into how resource-scarce regions can apply molecular-clinical models.
Authors
- Liya Ma (ORCID: https://orcid.org/0009-0000-6438-411X)
- Yingwan Luo (ORCID: https://orcid.org/0000-0002-4831-3941)
- Lingxu Jiang (ORCID: https://orcid.org/0000-0002-7742-0404)
- Hongyan Tong (ORCID: https://orcid.org/0000-0001-5603-4160)
- Wei Lang (ORCID: https://orcid.org/0000-0002-8853-4458)
- Xinping Zhou (ORCID: https://orcid.org/0000-0002-7920-1395)
- Ying Xu (ORCID: https://orcid.org/0000-0001-8497-5937)
- Wenli Yang (ORCID: https://orcid.org/0000-0002-1873-2336)
- Li Ye (ORCID: https://orcid.org/0000-0001-5303-2549)
- Xiaozhen Liu (ORCID: https://orcid.org/0000-0001-8901-5804)
- Yudi Zhang (ORCID: https://orcid.org/0000-0003-2597-3389)
- Lu Wang (ORCID: https://orcid.org/0009-0007-2430-7073)
- Wei Wang (ORCID: https://orcid.org/0000-0003-2044-6387)
Institutions
- Zhejiang Cancer Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1186/s12967-024-05995-x
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- National Natural Science Foundation of China